NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 144 filers reported holding NOVAVAX INC in Q3 2014. The put-call ratio across all filers is 5.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $30,000 | -96.6% | 24,190 | -94.2% | 0.00% | -100.0% |
| Q3 2016 | $870,000 | -73.0% | 418,340 | -5.8% | 0.00% | -70.0% |
| Q2 2016 | $3,228,000 | +16.3% | 443,966 | -17.5% | 0.01% | +11.1% |
| Q1 2016 | $2,775,000 | -43.8% | 537,864 | -8.5% | 0.01% | -35.7% |
| Q4 2015 | $4,934,000 | -14.2% | 588,062 | -27.7% | 0.01% | -22.2% |
| Q3 2015 | $5,750,000 | -44.1% | 813,330 | -11.8% | 0.02% | -28.0% |
| Q2 2015 | $10,278,000 | +59.1% | 922,649 | +18.1% | 0.02% | +66.7% |
| Q1 2015 | $6,462,000 | +62.8% | 781,420 | +16.7% | 0.02% | +50.0% |
| Q4 2014 | $3,970,000 | +46.7% | 669,474 | +3.1% | 0.01% | +66.7% |
| Q3 2014 | $2,707,000 | +105.1% | 649,240 | +127.2% | 0.01% | +100.0% |
| Q2 2014 | $1,320,000 | +2029.0% | 285,793 | +1975.0% | 0.00% | – |
| Q1 2014 | $62,000 | -27.9% | 13,773 | -18.2% | 0.00% | – |
| Q4 2013 | $86,000 | +138.9% | 16,837 | +49.0% | 0.00% | – |
| Q3 2013 | $36,000 | +38.5% | 11,297 | -11.7% | 0.00% | – |
| Q2 2013 | $26,000 | – | 12,792 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |